Exploring the potential of psychedelic-assisted psychotherapy for moral injury: A scoping review.
Viktoriia Kurkova, Olga Winkler, Andrew Greenshaw, Rakesh Jetly, Jennifer Swainson, Kalee Lodewyk, Parisa Saghafi, Elizabeth Dennett, Lisa Burback
Progress in neuro-psychopharmacology & biological psychiatry April 2, 2025 DOI: 10.1016/j.pnpbp.2025.111333 via PubMed
Summary
AI-generated from the abstractA scoping review of 10 studies out of 11,734 publications examined whether psychedelic-assisted psychotherapy (PAP) can help people recover from moral injury—deep distress from morally challenging experiences. None of the studies focused specifically on moral injury; they involved psilocybin, MDMA, or LSD for conditions such as PTSD, alcohol use disorder, depression, and anxiety. Across these studies, PAP was associated with rapid, sustained increases in self-compassion, self-forgiveness, and self-acceptance, along with reduced demoralization and lower drinking scores. The authors suggest PAP holds promise for treating moral injury, especially when it co-occurs with PTSD, but conclude that direct research is needed.
Study at a glance
| Characteristics | Scoping review Peer reviewed |
|---|---|
| Interventions | Psilocybin MDMA LSD |
| Topics | LSD MDMA Psilocybin Psychedelic-assisted therapy PTSD |
| Keywords | Moral injury Psychedelics |
| Key finding | Psychedelic-assisted psychotherapy shows promise for addressing symptoms commonly associated with moral injury, such as low self-compassion and demoralization, though no included study focused on moral injury directly. |
Abstract
This scoping review addresses the need to comprehensively explore the potential of psychedelic-assisted psychotherapy (PAP) to facilitate recovery from moral injury. Moral injury (MI), characterized by profound psychological distress arising from morally challenging experiences, has garnered increased attention as a complex mental health concern with significant functional sequelae, especially in the context of post-traumatic stress disorder (PTSD). There is growing interest in exploring alternative therapeutic approaches, with psychedelics emerging as an exciting potential intervention, as moral injury impacts treatment resistance, suicidality, social isolation, and overall functioning. Ten studies were included from 11,734 publications. Studies utilized psilocybin, MDMA, or LSD. None focused specifically on moral injury. Diagnoses included PTSD, alcohol use disorder, insomnia, human Immunodeficiency virus-related demoralized men, barbiturate dependence, anxiety associated with life-threatening illness, major depression, and PTSD comorbid with generalized anxiety disorder, panic disorder, and borderline personality disorder. Studies reported rapid, increasing, and sustained self-compassion over time, alongside increases in self-forgiveness and self-acceptance, reduction in demoralization, and decreased drinking scores. Though in other diagnostic contexts, PAP has shown efficacy in addressing symptoms commonly associated with moral injury, particularly within the context of PTSD. It holds promise as an intervention for MI and requires further exploration.